Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases.
- DOI
- 10.1615/critrevimmunol.2026062673
- Published
- 2026
- Container
- Critical reviews in immunology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1615/critrevimmunol.2026062673,
title = {Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases.},
author = {Jabbari S and Safaralizadeh R and Beilankouhi EAV and Valilo M and Hosseinpourfeizi M and Baradaran B and Khodavirdipour A and Hemmat N},
year = {2026},
journal = {Critical reviews in immunology},
doi = {10.1615/critrevimmunol.2026062673},
url = {https://doi.org/10.1615/critrevimmunol.2026062673}
}RIS
TY - JOUR TI - Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases. AU - Jabbari S AU - Safaralizadeh R AU - Beilankouhi EAV AU - Valilo M AU - Hosseinpourfeizi M AU - Baradaran B AU - Khodavirdipour A AU - Hemmat N PY - 2026 JO - Critical reviews in immunology DO - 10.1615/critrevimmunol.2026062673 UR - https://doi.org/10.1615/critrevimmunol.2026062673 ER -
APA
S, J., R, S., EAV, B., M, V., M, H., B, B., A, K., & N, H. (2026). Leveraging Type I Interferons: Exploring Pathogenesis and Therapeutic Strategies in Autoimmune Diseases.. Critical reviews in immunology. https://doi.org/10.1615/critrevimmunol.2026062673
Source records
- pubmed · retrieved 2026-09-26T15:52:18.037Z
- europe-pmc · retrieved 2026-09-26T15:52:18.048Z